242PBIOMARKER ANALYSIS OF A PHASE 1 STUDY OF MM-111, A...

Annals of Oncology 2014 / 09 Vol. 25; Iss. suppl_4

242PBIOMARKER ANALYSIS OF A PHASE 1 STUDY OF MM-111, A BISPECIFIC HER2/HER3 ANTIBODY FUSION PROTEIN, IN COMBINATION WITH MULTIPLE TREATMENT REGIMENS IN PATIENTS WITH ADVANCED HER2 POSITIVE SOLID TUMORS

Kudla, A., Adiwijaya, B., Paragas, V., Richards, D., Braiteh, F., Garcia, A.A., Denlinger, C.S., Conkling, P., Edenfield, W.J., Anthony, S., Hellerstedt, B., Raju, R., Becerra, C., Harb, W., Smith, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu326.75
Date:
September, 2014
File:
PDF, 64 KB
english, 2014
Conversion to is in progress
Conversion to is failed